No cure, no pay

BMJ. 2005 May 28;330(7502):1262-4. doi: 10.1136/bmj.330.7502.1262.

Abstract

Not paying for a drug unless it works sounds great for patients and healthcare funders, but it could also benefit manufacturers.

Publication types

  • Review

MeSH terms

  • Drug Industry / economics
  • Fees, Pharmaceutical*
  • Health Policy
  • Humans
  • Pharmaceutical Preparations / economics*
  • Treatment Failure

Substances

  • Pharmaceutical Preparations